We are live on ! Find out more
FCSC

Fibrocell Science Inc.
FCSC

Delisted

FCSC was delisted on the 12th of December, 2019.

0 hedge funds and large institutions have $0 invested in Fibrocell Science Inc. in 2019 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 220 (-22)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

100% less capital invested

Capital invested by funds: $10.6M → $0 (-$10.6M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 22

Holders
Holders Change
-22
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
22
Calls
Puts
Net Calls
Net Calls Change

FCSC Hedge Fund Activity: Q4 2019 in Review

0 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Fibrocell Science Inc. (FCSC) for Q4 2019, worth a combined $0 — down 100% from $10.6M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of FCSC and 0 opened new positions — a net loss of 22 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Third Security, exiting entirely with an estimated $4.89M sold.

  • 0 institutional investors held Fibrocell Science Inc. (FCSC) as of Q4 2019, down from 22 in Q3 2019.
  • Funds reported $0 of Fibrocell Science Inc. stock for Q4 2019, down 100% quarter-over-quarter.
  • 0 funds opened new Fibrocell Science Inc. positions in Q4 2019 and 22 closed out, a net change of -22 holders.
  • The largest Fibrocell Science Inc. seller in Q4 2019 was Third Security, an estimated $4.89M sold.

Based on aggregated 13F filings for Q4 2019.